Study guide

9.4 Biliary Tract Diseases & Pancreatitis

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

9.4 Biliary Tract Diseases & Pancreatitis

Key Takeaways Explain This Topic AI

Acute cholecystitis presents with right upper quadrant pain, fever, leukocytosis, and a positive Murphy sign; ultrasound showing gallbladder wall thickening >4 mm or pericholecystic fluid is diagnostic.

Acute ascending cholangitis presents with Charcot triad (fever, RUQ pain, jaundice) or Reynolds pentad (Charcot triad + hypotension + altered mental status), requiring urgent biliary decompression via ERCP.

Acute pancreatitis diagnosis requires at least 2 of 3 criteria: severe epigastric pain radiating to the back, serum lipase or amylase >3 times upper limit of normal, and characteristic abdominal imaging findings.

Ranson criteria and BISAP score assess acute pancreatitis severity; dynamic contrast-enhanced CT of the abdomen at 72 hours evaluates pancreatic necrosis.

Chronic pancreatitis presents with the triad of pancreatic calcifications on imaging, steatorrhea (>7 g/24h stool fat), and diabetes mellitus, managed with pancreatic enzyme replacement (lipase) and pain control.

Last updated: July 2026

9.4 Biliary Tract Diseases & Pancreatitis

High-Yield Overview: Disorders of the biliary tree and pancreas represent frequent emergency department presentations. Clinical mastery requires distinguishing localized gallbladder disease (cholecystitis) from common bile duct obstruction (choledocholithiasis, cholangitis) and applying evidence-based diagnostic criteria and fluid resuscitation strategies for acute and chronic pancreatitis.

Spectrum of Biliary Tract Disease

Biliary tract pathology depends on the exact anatomical site of ductal obstruction and the presence of bacterial infection.

Condition Anatomical Site of Obstruction Clinical Presentation Diagnostic Findings Management

Biliary Colic Transient cystic duct obstruction Postprandial RUQ/epigastric dull pain (<6 hours), nausea; no fever or leukocytosis RUQ Ultrasound shows gallstones without wall thickening Elective laparoscopic cholecystectomy

Acute Cholecystitis Persistent cystic duct obstruction RUQ pain >6 hours, fever, leukocytosis, positive Murphy sign RUQ US: Gallbladder wall >4 mm, pericholecystic fluid IV antibiotics + Laparoscopic cholecystectomy within 72 hours

Choledocholithiasis Common bile duct (CBD) obstruction RUQ pain, jaundice , dark urine, elevated Alk Phos & conjugated bilirubin RUQ US: Dilated CBD (>6 mm) or stone visualization ERCP with sphincterotomy & stone extraction, followed by cholecystectomy

Acute Ascending Cholangitis CBD obstruction + superinfected bile Charcot Triad (Fever, RUQ pain, Jaundice) or Reynolds Pentad (+ Hypotension, Altered mental status) Biliary ductal dilation; elevated transaminases & bilirubin Emergency ERCP biliary drainage + broad-spectrum IV antibiotics

Gallstone Ileus Cholecystoenteric fistula (usually duodenal) Mechanical small bowel obstruction in elderly female CT Abdomen ( Rigler Triad : SBO, gallstone in ectopic lumen, pneumobilia) Emergency surgical enterolithotomy

  • Diagnostic Algorithms for Biliary Disease Suspected Biliary Tract Symptoms
  • |
  • Initial RUQ Abdominal Ultrasound
  • |
  • +------------------------+------------------------+
  • | |
  • Gallstones + Wall Thickening (>4mm) CBD Dilation (>6mm) OR
  • OR Pericholecystic Fluid Jaundice / Elevated Bilirubin
  • | |
  • Acute Cholecystitis Assess Cholangitis Risk
  • | |
  • +----+----+ +-------+-------+
  • | | | |
  • Equivocal Confirmed Charcot Triad No Infection
  • | | (Emergency ERCP) |
  • HIDA Scan Laparoscopic MRCP or EUS
  • (No Fill) Cholecystectomy before ERCP

First-Line Modality: Right Upper Quadrant Abdominal Ultrasound is the initial diagnostic test for all suspected biliary pathology (>95% sensitivity for gallstones).

Equivocal Cholecystitis: Perform HIDA Scan (Cholescintigraphy) . Failure of radiotracer to visualize the gallbladder due to cystic duct obstruction confirms acute cholecystitis.

Choledocholithiasis Stratification:

High Risk (Jaundice, visible stone on US, ascending cholangitis): Proceed directly to ERCP .

Intermediate Risk (CBD dilation >6 mm, elevated Alk Phos/transaminases): Perform MRCP or Endoscopic Ultrasound (EUS) to confirm stone presence prior to invasive therapeutic ERCP.

  • Acute Pancreatitis: Etiology, Diagnosis & Staging
  • Etiologies

Gallstones (40%): Most common cause overall.

Alcohol (30%): Second most common cause.

Hypertriglyceridemia (1-4%): Serum triglycerides >1000 mg/dL .

Post-ERCP: Occurs in 3-5% of procedures.

Medications: Azathioprine, 6-MP, valproic acid, thiazides, furosemide, didanosine.

Hypercalcemia, Trauma, Autoimmune, Scorpion Stings.

Diagnostic Criteria (Requires >=2 of 3 Criteria)

Acute onset of severe, persistent epigastric pain radiating to the back .

Serum Lipase or Amylase >3 times the upper limit of normal (Lipase is more specific and remains elevated for 8-14 days).

Characteristic cross-sectional abdominal imaging findings (contrast-enhanced CT, MRI, or ultrasound).

Clinical Note: Abdominal CT is NOT required on admission if criteria 1 and 2 are satisfied. Contrast-Enhanced CT (CECT) should be performed at 72 hours after presentation to accurately evaluate for pancreatic necrosis if the patient fails to improve.

Severity Assessment & Clinical Signs

BISAP Score (Evaluated within first 24h): B UN >25 mg/dL, I mpaired mental status (GCS <15), S IRS criteria met, A ge >60, P leural effusion present. Score >=3 indicates high mortality risk.

Physical Signs of Severe Hemorrhagic Pancreatitis:

Grey Turner Sign: Flank ecchymosis.

Cullen Sign: Periumbilical ecchymosis.

Acute Medical Management Principles

Fluid Resuscitation: Aggressive IV isotonic crystalloids ( Lactated Ringer's at 200–500 mL/hr or 5–10 mL/kg/hr) to maintain urine output >0.5 mL/kg/hr.

Pain Management: IV opioids (hydromorphone, fentanyl).

Nutrition: Early oral/enteral feeding within 24–48 hours is preferred over TPN to preserve the gut mucosal barrier and prevent bacterial translocation.

Antibiotics: Prophylactic antibiotics are not recommended for uninfected pancreatitis or sterile necrosis.

  • Complications of Acute & Chronic Pancreatitis
  • Local Complications of Acute Pancreatitis

Pancreatic Pseudocyst: Fluid collection rich in pancreatic enzymes encapsulated by fibrous/granulation tissue (lacks an epithelial lining) . Forms >4 weeks after acute pancreatitis.

Management: Asymptomatic <6 cm -> Observation; Symptomatic, infected, or >6 cm persisting >6 weeks -> Endoscopic transmural drainage (cystogastrostomy) .

Infected Pancreatic Necrosis: Suspected when a patient develops fever, leukocytosis, and clinical deterioration 2 to 3 weeks into the hospital course. CT shows gas bubbles within necrotic tissue. Treatment includes broad-spectrum IV antibiotics (imipenem, meropenem) and delayed endoscopic/surgical necrosectomy (>4 weeks post-onset).

Chronic Pancreatitis

Progressive, irreversible pancreatic parenchyma destruction and fibrosis, primarily caused by chronic alcohol abuse (>70%) or cystic fibrosis ( CFTR mutations).

Classic Diagnostic Triad:

Pancreatic Calcifications: Visible on plain abdominal X-ray or CT.

Steatorrhea: Fat malabsorption leading to bulky, foul-smelling stools (fecal elastase-1 <200 mcg/g or 24-hour fecal fat >7 g/day).

Diabetes Mellitus: Pancreatogenic (Type 3c) diabetes from beta-cell destruction.

Management: Alcohol and tobacco cessation, Pancreatic Enzyme Replacement Therapy (PERT) taken WITH meals, low-fat diet, and insulin for glycemic control.